Survival benefit stratification of partial nephrectomy versus non‐surgical treatment in elderly patients with T1a renal cell carcinoma

Renal cell carcinoma (RCC) of stage T1a has been proven to be of low‐grade malignancy and mostly affects elderly individuals with relatively limited life expectancy. However, research on the survival benefit of surgery relative to non‐surgical treatment (NST) is limited. The aim of the study was to investigate the survival difference between partial nephrectomy (PN) and NST and to establish a benefit stratification model for elderly patients (≥70 years) diagnosed with T1a RCC.

[1]  U. Capitanio,et al.  European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. , 2022, European urology.

[2]  S. Hancock,et al.  Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  Sam S. Chang,et al.  Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I , 2021, The Journal of urology.

[4]  F. Saad,et al.  Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study. , 2021, Urologic oncology.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  F. Saad,et al.  Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  A. Evans,et al.  Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort. , 2020, European urology.

[8]  F. Saad,et al.  Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study. , 2020, European urology focus.

[9]  J. Ludwig,et al.  Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study. , 2018, Radiology.

[10]  Mark W. Ball,et al.  Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. , 2015, European urology.

[11]  P. Karakiewicz,et al.  1634 MANAGEMENT OF LOCALIZED KIDNEY CANCER: CALCULATING CANCER-SPECIFIC MORTALITY AND COMPETING-RISKS OF DEATH TRADEOFFS BETWEEN SURGERY AND ACTIVE SURVEILLANCE , 2013 .

[12]  P. Pierorazio,et al.  633 QUALITY OF LIFE ON ACTIVE SURVEILLANCE FOR A SMALL RENAL MASSES VERSUS IMMEDIATE INTERVENTION: INTERIM ANALYSIS OF THE DISSRM (DELAYED INTERVENTION AND SURVEILLANCE FOR SMALL RENAL MASSES) REGISTRY , 2013 .

[13]  W. Lowrance,et al.  Surveillance for the management of small renal masses: Utilization and outcomes in a population-based cohort. , 2013, Journal of Clinical Oncology.

[14]  P. Pierorazio,et al.  1679 PARTIAL NEPHRECTOMY VS. NON-SURGICAL MANAGEMENT FOR SMALL RENAL MASSES: A POPULATION-BASED COMPARISON OF DISEASE-SPECIFIC AND OVERALL SURVIVAL , 2012 .

[15]  A. Evans,et al.  Active surveillance of small renal masses: progression patterns of early stage kidney cancer. , 2011, European urology.

[16]  L. Klotz,et al.  Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. , 2011, European urology.

[17]  J. Kaouk,et al.  Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older , 2010, Cancer.

[18]  J. Patard,et al.  A population‐based comparison of survival after nephrectomy vs nonsurgical management for small renal masses , 2009, BJU international.

[19]  T. Klatte,et al.  Surveillance for the Management of Small Renal Masses , 2008, Advances in urology.

[20]  M. Cooperberg,et al.  Renal cell cancer stage migration , 2008, Cancer.

[21]  I. Gill,et al.  The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. , 2006, The Journal of urology.

[22]  Jeff Scott.  Renal Cell , 2020, Definitions.

[23]  W. Chow,et al.  Global increases in kidney cancer incidence, 1973–1992 , 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.